National Health Investors (NYSE:NHI) Price Target Cut to $81.00 by Analysts at Truist Financial

National Health Investors (NYSE:NHI) had its price objective decreased by research analysts at Truist Financial from $89.00 to $81.00 in a research note issued to investors on Friday,Benzinga reports. The firm currently has a “buy” rating on the real estate investment trust’s stock. Truist Financial’s price target suggests a potential upside of 12.20% from the stock’s previous close.

NHI has been the subject of several other research reports. Weiss Ratings restated a “buy (b)” rating on shares of National Health Investors in a research report on Friday, March 27th. Wells Fargo & Company dropped their target price on National Health Investors from $84.00 to $79.00 and set an “equal weight” rating for the company in a research report on Monday, June 1st. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $94.00 price target on shares of National Health Investors in a research note on Wednesday, April 22nd. One analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, National Health Investors has an average rating of “Moderate Buy” and an average price target of $85.33.

National Health Investors Price Performance

Shares of NYSE:NHI traded up $0.23 during midday trading on Friday, reaching $72.19. The company’s stock had a trading volume of 10,799 shares, compared to its average volume of 342,343. The business’s fifty day simple moving average is $77.48 and its 200-day simple moving average is $80.14. The company has a debt-to-equity ratio of 0.83, a current ratio of 8.20 and a quick ratio of 8.20. National Health Investors has a fifty-two week low of $67.94 and a fifty-two week high of $91.38. The company has a market capitalization of $3.50 billion, a P/E ratio of 23.30, a P/E/G ratio of 3.79 and a beta of 0.52.

National Health Investors (NYSE:NHI) last issued its quarterly earnings data on Monday, May 4th. The real estate investment trust reported $0.82 EPS for the quarter, missing analysts’ consensus estimates of $1.21 by ($0.39). National Health Investors had a return on equity of 9.82% and a net margin of 36.86%.The company had revenue of $115.13 million for the quarter, compared to the consensus estimate of $70.22 million. During the same period in the prior year, the company earned $1.15 EPS. The firm’s revenue was up 28.9% compared to the same quarter last year. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. As a group, equities research analysts expect that National Health Investors will post 5.07 EPS for the current fiscal year.

Insider Activity at National Health Investors

In other news, CEO D. Eric Mendelsohn purchased 1,500 shares of the business’s stock in a transaction that occurred on Friday, June 5th. The shares were acquired at an average cost of $68.84 per share, for a total transaction of $103,260.00. Following the transaction, the chief executive officer directly owned 133,316 shares of the company’s stock, valued at approximately $9,177,473.44. The trade was a 1.14% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this link. 2.70% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. NewEdge Advisors LLC raised its holdings in National Health Investors by 18.1% in the first quarter. NewEdge Advisors LLC now owns 12,046 shares of the real estate investment trust’s stock worth $974,000 after purchasing an additional 1,844 shares during the period. Bank of America Corp DE raised its stake in National Health Investors by 20.0% during the 1st quarter. Bank of America Corp DE now owns 992,802 shares of the real estate investment trust’s stock worth $80,278,000 after buying an additional 165,467 shares during the period. Janus Henderson Group PLC grew its stake in National Health Investors by 14.9% in the first quarter. Janus Henderson Group PLC now owns 22,409 shares of the real estate investment trust’s stock valued at $1,812,000 after acquiring an additional 2,900 shares during the period. Amundi increased its holdings in shares of National Health Investors by 5.2% in the first quarter. Amundi now owns 24,866 shares of the real estate investment trust’s stock worth $2,011,000 after acquiring an additional 1,225 shares in the last quarter. Finally, EverSource Wealth Advisors LLC raised its position in shares of National Health Investors by 34.3% during the first quarter. EverSource Wealth Advisors LLC now owns 626 shares of the real estate investment trust’s stock worth $51,000 after purchasing an additional 160 shares during the period. Institutional investors and hedge funds own 62.51% of the company’s stock.

National Health Investors Company Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.